SUPPLEMENT

Q1 2021 — Condensed Consolidated Statement of Earnings

Q1 2021PDF · 1 pages18 KB
Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent 	Percent 	Increase
Amount 	to Sales 	Amount 	to Sales 	(Decrease)
Sales to customers 	22,321	$ 	100.0 	20,691	$ 	100.0 	7.9
Cost of products sold 	7,063 	31.7 	7,062 	34.1 	0.0
Gross Profit 	15,258 	68.3 	13,629 	65.9 	12.0
Selling, marketing and administrative expenses 	5,432 	24.3 	5,203 	25.1 	4.4
Research and development expense 	3,178 	14.2 	2,580 	12.5 	23.2
Interest (income) expense, net 	48 	0.2 	(42) 	(0.2)
Other (income) expense, net 	(882) 	(3.9) 	(679) 	(3.3)
Restructuring 	53 	0.2 	58 	0.3
Earnings before provision for taxes on income 	7,429 	33.3 	6,509 	31.5 	14.1
Provision for taxes on income 	1,232 	5.5 	713 	3.5 	72.8
Net earnings 	6,197 	27.8 	5,796 	28.0 	6.9
Net earnings per share (Diluted) 	2.32	$ 	2.17	$ 	6.9
Average shares outstanding (Diluted) 	2,672.7 	2,671.0
Effective tax rate 	16.6 % 	11.0 %
Adjusted earnings before provision for taxes and net earnings (1)
Earnings before provision for taxes on income 	8,291	$ 	37.1 	7,244	$ 	35.0 	14.5
Net earnings 	6,924	$ 	31.0 	6,154	$ 	29.7 	12.5
Net earnings per share (Diluted) 	2.59	$ 	2.30	$ 	12.6
Effective tax rate 	16.5 % 	15.0 %
(1) See Reconciliation of Non-GAAP Financial Measures.
FIRST QUARTER
2021 	2020

-- 1 of 1 --